Amarin Outperforms Medical Sector with 73.3% YTD Return

Amarin (AMRN) is outperforming its peers in the Medical sector this year, returning 73.3% compared to the sector's -2.7% average. The stock has a Zacks Rank of #1 (Strong Buy) and a 54.1% increase in full-year earnings estimates over the past 90 days. Abbott (ABT) is another Medical stock outperforming the sector, returning 20.5% this year with a Zacks Rank of #2 (Buy).